糖尿血管神經病 | Diabetic Vascular Neuropathy

糖尿血管病

糖尿病慢性高血糖的後遺症分為微血管併發症和大血管併發症。微血管疾病導致失明、腎功能衰竭和神經病變，糖尿病加速的大血管疾病導致心肌梗死、中風和下肢截肢的風險過高。慢性高血糖與血管損傷之間的聯系已由四個獨立的生化异常建立：多元醇途徑流量新增、晚期糖基化終產物（AGEs）形成新增、蛋白激酶C（PKC）啟動和己糖胺途徑流量新增。這些看似不相關的途徑有一個潜在的共同點：線粒體電子傳遞鏈產生過多的超氧物。線粒體活性氧（ROS）部分抑制糖酵解酶甘油醛-3-磷酸脫氫酶，將新增的底物流量從糖酵解轉移到葡萄糖過度利用途徑。初步的體內實驗證據表明，這一新範式為研究和藥物開發提供了新的基礎。

糖尿血管病-多學科研證復康方案

• 藥物及其他醫療方案,請遵醫從醫生建議
• 飲食營養請依營養師指引
• 運動及或心理輔導,請參考各專家建議

• 為免錯誤診斷及漏診,請上傳最近一個月醫院的專業診斷報告,如證實是此症,則可參加試用期不如意退款計劃#。

可能適合的補充劑支援:

標準組合:

1. 血糖研究 X4
2. 酶素研究 X2
   
3. 螯合研究 X6
4. 鈣化研究霜劑 X6
5. 睡眠研究 X1
6. 心脑血管研究 X2
7. 糖化新研究 X6

• 試用時期: 6 星期

# <試用期不如意退款計劃>,請參考相關文件

Diabetic Angiopathy

Microvascular disease causes blindness, renal failure, and neuropathy, and diabetes-accelerated macrovascular disease causes excessive risk for myocardial infarction, stroke, and lower limb amputation. The link between chronic hyperglycemia and vascular damage has been established by four independent biochemical abnormalities: increased polyol pathway flux, increased formation of advanced glycation end-products (AGEs), activation of protein kinase C (PKC), and increased hexosamine pathway flux. These seemingly unrelated pathways have an underlying common denominator: overproduction of superoxide by the mitochondrial electron transport chain. Mitochondrial reactive oxygen species (ROS) partially inhibit the glycolytic enzymes glyceraldehyde-3-phosphate dehydrogenase, which diverts increased substrate flux from glycolysis to pathways of glucose overutilization. Preliminary experimental evidence in vivo suggests that this new paradigm provides a novel basis for research and drug development.

Multidisciplinary research and rehabilitation program for Diabetic Angiopathy

• Please follow the doctor's advice for drugs and other medical plans
• Please follow the guidance of nutritionist
• For sports or psychological counseling, please refer to the experts' suggestions
• In order to avoid misdiagnosis and missed diagnosis, please upload the professional diagnosis report of the hospital in the latest month. If it is confirmed to be this disease, you can participate in the .#

Possible supplements supporting:

Standard combination:

• Blood-Sugar-Study X4
• Scienzyme Study X2
  
• Chelation-Study X6
• Calcification Study Cream X6
• Sleeping Study X1
  
• Vascular Study X2

• Glycation Study X6

Trial period: 6 weeks

# Please refer to the relevant documents for the

If you have this disease, please follow your doctor's complete medical plan. You must consult the attending doctor before using the multidisciplinary rehabilitation plan. If your attending doctor does not recommend you to join the supplement conditioning combination, please do not use it. If you need to seek second opinion from other doctors, you can contact our online "Doctors Without Borders", or another professional doctor in your own city.